ArticleCells2022

Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer.

Xiaxia Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.